Pharsight

1. List of Children's Allegra Allergy drug patents

^new

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8933097	CHATTEM SANOFI	Fexofenadine suspension formulation	Aug, 2030 (7 years from now)

Market Authorisation Date: 24 January, 2011

Treatment: NA

Dosage: SUSPENSION;ORAL

CHILDREN'S ALLEGRA ALLERGY family patents

3

United States

1

Poland

1

Canada

1

Dominican Republic

1

Slovenia

1

Korea, Republic of

1

Ukraine

1

Egypt

1

Brazil

1

Hong Kong

1

Costa Rica

1

Taiwan

1

China

1

Germany

1

Japan

1

Morocco

1

RS

1

Honduras

1

Cyprus

1

Denmark

1

Croatia

1

Malaysia

1

Argentina

1

Uruguay

1

Spain

1

New Zealand

1

Australia

1

Norway

1

South Africa

1

Austria

1

Ecuador

1

Portugal

1

Tunisia

1

Russia

1

Israel

1

Jordan

1

Peru

1

European Union

^new

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in

Drugs that contains Fidaxomicin

Drugs expiring in 2030